Shanghai Yizhong Pharmaceutical Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Shanghai Yizhong Pharmaceutical has a total shareholder equity of CN¥1.4B and total debt of CN¥10.9M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are CN¥1.5B and CN¥50.9M respectively. Shanghai Yizhong Pharmaceutical's EBIT is CN¥53.9M making its interest coverage ratio -19.2. It has cash and short-term investments of CN¥654.1M.
Belangrijke informatie
0.8%
Verhouding schuld/eigen vermogen
CN¥10.91m
Schuld
| Rente dekkingsratio | -19.2x |
| Contant | CN¥654.14m |
| Aandelen | CN¥1.44b |
| Totaal verplichtingen | CN¥50.90m |
| Totaal activa | CN¥1.49b |
Recente financiële gezondheidsupdates
Recent updates
There's Reason For Concern Over Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) Massive 34% Price Jump
Oct 01
Is Shanghai Yizhong Pharmaceutical (SHSE:688091) Using Too Much Debt?
Aug 20What Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) P/E Is Not Telling You
Jul 24Concerns Surrounding Shanghai Yizhong Pharmaceutical's (SHSE:688091) Performance
Apr 15Getting In Cheap On Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE:688091) Is Unlikely
Mar 29Analyse van de financiële positie
Kortlopende schulden: 688091's short term assets (CN¥845.8M) exceed its short term liabilities (CN¥47.0M).
Langlopende schulden: 688091's short term assets (CN¥845.8M) exceed its long term liabilities (CN¥3.9M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 688091 has more cash than its total debt.
Schuld verminderen: 688091's debt to equity ratio has increased from 0% to 0.8% over the past 5 years.
Schuldendekking: 688091's debt is well covered by operating cash flow (409.8%).
Rentedekking: 688091 earns more interest than it pays, so coverage of interest payments is not a concern.